DRUG-RESISTANCE OF MYCOBACTERIUM-TUBERCULOSIS STRAINS ISOLATED FROM HIV-INFECTED ITALIAN PATIENTS - PRELIMINARY-REPORT FROM A MULTICENTRIC STUDY

Citation
G. Angarano et al., DRUG-RESISTANCE OF MYCOBACTERIUM-TUBERCULOSIS STRAINS ISOLATED FROM HIV-INFECTED ITALIAN PATIENTS - PRELIMINARY-REPORT FROM A MULTICENTRIC STUDY, The New microbiologica, 18(1), 1995, pp. 69-72
Citations number
NO
Categorie Soggetti
Microbiology
Journal title
The New microbiologica
ISSN journal
11217138 → ACNP
Volume
18
Issue
1
Year of publication
1995
Pages
69 - 72
Database
ISI
SICI code
1121-7138(1995)18:1<69:DOMSIF>2.0.ZU;2-W
Abstract
A multicentric prospective study started in March '93 to describe both initial and acquired resistance of Mycobacterium Tuberculosis in Ital ian HIV+ patients (Pyrazinamide (pts.) to first line drugs: Rifampin ( R), Isoniazid (I), Pyrazinamide (P), Ethambutol (E), Streptomycin (S). All tuberculosis (TB) cases diagnosed in HIV+ patients (pts.) were in cluded, along with clinical-anamnestical data. Drug-susceptibility tes ts were performed centrally. Preliminary results indicate an overall l ow frequency of TB resistance to first line drugs: R=2%, P=4%, S=9%, I /E=none. However, a relevant nosocomial outbreak of multiple drug resi stant (DR) TB was detected. This finding, along with some previous Ita lian reports of DR-TB clusters, may herald a further spread of DR-TB. Surveillance, therefore, is mandatory in Italy from now on.